Exenatideacetate

CAS: 141732-76-5
Molecular Formula: C184H282N50O60S
Molecular Weight: 4186.6
Product description:Im fall blood sugar, such as glucagon like peptide 1 (glp-1), from the intestinal released into the circulation after dependence may improve glucose insulin secretion, and show the other high blood sugar medicine resistant. Asay the peptide is quasi im fall blood sugar, medicine, can simulate glucose dependent function and intestinal fall blood sugar, insulin secretion increase other resisting high blood sugar medicine. Essex the peptide sequence of amino acids and human glp-1 overlap. Essex in vitro showed that peptides can combine and activation of known human glp-1 receptor. This means that by including cAMP and/or other intracellular signal transduction mechanisms of glucose insulin dependent synthesis and islet beta cells secrete insulin in the body. In the case of elevated glucose concentration, Essex peptide can promote the insulin release from the beta cells. Body after dosing asay the glp-1 peptides simulation of a certain resistance to high blood sugar medicine effect.